Earthtimes, Dec. 11, 2006,33127.shtml OrthoLogic Corp. today announced results of experiments that advance the basic science supporting its novel synthetic peptide Chrysalin (TP508). Two posters are being presented at the American Society for Cell Biology 46th Annual Meeting in San Diego, Dec. 9 - 13, 2006. "The experiments being presented at this year's ASCB Annual Meeting help to further our understanding of the basic science behind this exciting molecule," said Darrell H. Carney, Ph.D., Professor of Biochemistry and Molecular Biology at The University of Texas Medical Branch, Galveston. "We have gained greater insight into how TP508 stimulates repair and revascularization of tissues; we believe that endothelial cells play a key role in a number of effects."